Validacija sprske verzije upitnika za procenu hronične opstruktivne bolesti pluća

  • Branislava Milenković Clinical Center of Serbia, Clinic for Pulmonology, Belgrade, Serbia
  • Sanja Dimić Janjić Clinical Center of Serbia, Clinic for Pulmonology, Belgrade, Serbia
  • Jelena Kotur-Stevuljević University of Belgrade, Faculty of Pharmacy, Department for Molecular Biochemistry, Belgade, Serbia
  • Ivan Kopitović University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Jelena Janković Clinical Center of Serbia, Clinic for Pulmonology, Belgrade, Serbia
  • Mihailo Stjepanović Clinical Center of Serbia, Clinic for Pulmonology, Belgrade, Serbia
  • Marija Vukoja University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Snežana Ristić Institute for Students Health Care, Belgrade, Serbia
  • Žaklina Davičević-Elez GlaxoSmithKline, Medical Department, Belgrade, Serbia
DOI: https://doi.org/10.2298/VSP180220094M
Ključne reči: pluća, opstruktivne bolesti, hronične, ankete i upitnici, srbija, komorbiditet, ekspiratorni volumen, forsirani

Sažetak


Uvod/Cilj. Upitnik za procenu hronične opstruktivne bolesti pluća (HOBP) (engl. COPD Assessment Test - CAT) je jednostavan i pouzdan test namenjen za merenje ukupnog zdravstvenog stanja bolesnika sa HOBP i koristan je za upo­trebu u svakodnevnoj kliničkoj praksi. Cilj ovog istraživanja bio je da se proceni validnost i opravdanost primene srpske verzije CAT. Metode. U studiji je učestvovalo 140 boles­nika u stabilnom stanju HOBP, ispitivanih u ambulantnim uslovima na Klinici za pulmologiju, Kliničkog centra Srbije u Beogradu i Institutu za plućne bolesti Vojvodine u Sremskoj Kamenici. Tokom prvog pregleda bolesnicima je učinjeno ispitivanje plućne funkcije (spirometrija), popunili su CAT upitnik i mMMR (modified Medical Research Council) skalu za procenu stepena dispneje. Pouzdanost CAT test-retesta je ispitivana kod 20 bolesnika od strane istog istraživača. Rezultati. Pokazali smo da srpska verzija CAT ima visoku internu konzistentnost sa Cronbach-ovim alfa 0.88. Test-retest analiza pokazala je dobru korelaciju između CAT rezultata u dve vremenske tačke (Spearmanov r = 0,681; p < 0,01). CAT je umereno korelirao sa mMRC skalom (r = + 0,57), blago sa forsiranim ekspiratornim volumenom u prvoj sekundi (FEV1), (r -0,214), uz pozitivnu korelaciju sa ukupnim brojem pogoršanja HOBP, ali bez jasne regularnosti sa promenom GOLD (Global Initiative for Chronic Obstructive Lung Disease) stadijuma. Zaključak. Srpska verzija CAT je pokazala visoku internu konzi­stent­nost i test-retest pouzdanost. Ona predstavlja pouzdano, jednostavno i lako sredstvo za upotrebu koje se može ko­ris­titi u svakodnevnoj kliničkoj praksi za procenu zdrav­stve­nog stanja kod bolesnika sa HOBP u Srbiji.

Reference

Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://goldcopd.org.

Adeloye D, Chua S, Lee Ch, Basquill C, Papana A, Theodoraton E, et al. Global and regional estimates of COPD prevalence: Sys-tematic review and meta-analysis. J Glob Health 2015; 5(2): 020415.

Milenkovic B, Mitic-Milikic M, Rebic P, Vukcevic M, Dudvarski-Ilic A, Nagorni-Obradovic L, et al. Asthma and chronic bronchitis symptoms among adult population of Belgrade. Srp Arh Celok Lek 2011; 139 (3–4): 149–54.

Vukoja M, Rebic P, Lazic Y, Mitic-Milikic M, Milenkovic B, Zvezdin B, et al. Early detection of asthma and chronic ob-structive pulmonary disease in primare care patients. Med Pregl 2013; 66(1–2): 46–52.

Jones PW, Quirk FH, Baveystock CM. The St George s Respira-tory Questionnaire. Respir Med 1991; 85 Suppl B: 25–31 dis-cussion 33–7.

Larson JL, Covey MK, Berry JK, Wirtz S, Kim MJ. Reliability and validity of the Chronic Respiratory Disease Question-naire. Am Rev Respir Dis 1993; 147: A 530.

van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsive-ness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1: 13.

Jones PW, Harding G, Berry P, Wiklung I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assess-ment Test. Eur Respir J 2009; 34(3): 648–54.

COPD Assessment Test. Available from: http://www.catestonline.org/.

Miller MR, Hankinson J, Brusasco V, Burgas V, Burgas F, Casa-buri R, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2): 319–38.

Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomi-oka R, et al. Development of the Japanese version of the COPD Assessment Test. Respir Investig 2012; 50(2): 34–9.

Kwon N, Amin M, Hui DS, Jung KS, Lim SY, Ta HD, et al. Val-idaty of the COPD assessment test translatedi Into local lan-guages for Asian patients. Chest 2013; 143(3): 703–10.

Pothirat C, Kiatboonsri S, Chuchattaworn C. Validation of the new COPD assess-ment test translated into Thai in patients with chronic obstructive pulmonary disease. BMC Pulm Med 2014; 14: 193.

Silva GP, Morano MT, Viana CM, Magalhães CB, Pereira ED. Portuguese-language version of the COPD Assessment Test: validation for use in Brazil. J Bras Pneumol 2013; 39(4): 402–8. (English, Portuguese)

Yorgancıoğlu A, Şakar Coşkun A. Is the diagnosis of asthma different in elderly? Tuberk Toraks 2012; 60(1): 81–5.

Fakharian A, Masouleh SK, Karimzadeh S, Farhadi T. Validation of the COPD assessment test in patients with COPD in Iran. Chron Obstruct Pulmon Dis 2017; 2: 22.

Al-Moamary MS, Al-Hajjaj MS, Tamim HM, Al-Ghobain MO, Al-Qahtam HA, Al-Kassimi FA. The reliability of an Arabic translation of the chronic obstructive pulmonary disease as-sessment test. Saudi Med J 2011; 32(10): 1028–33.

Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assess-ment test: a systematic review. Eur Resp J 2014; 44(4): 873–84.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38(1): 29–35.

Gao Y, Hou Q, Wang H. Assessment of Health Status in Pa-tients with Newly Diagnosed Chronic Obstructive Pulmonary Disease. PloS One 2013; 8(12): e82782.

Varol Y, Ozacar R, Balci G, Usta L, Taymaz Z. Assessing the effectiveness of the COPD Assessment Test (CAT) to evalu-ate COPD severity and exacerbation rates. COPD. 2014; 11(2): 221–5.

Agustí A, Soler JJ, Molina J, Muñoz MJ, García-Losa M, Roset M, et al. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations? COPD 2012; 9(5): 492–8.

Objavljeno
2021/08/04
Broj časopisa
Vol. 77 Br. 3 (2020): Vojnosanitetski pregled
Rubrika
Originalni članak